Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
13 October 2021Website:
http://www.bonebiologics.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Thu, 20 Jun 2024 23:58:08 GMTDividend
Analysts recommendations
Institutional Ownership
BBLG Latest News
Bone Biologics (NASDAQ: BBLG ) stock is falling on Friday after the medical device company's shares underwent a major rally the day prior. That rally was caused by heavy trading of BBLG stock.
Bone Biologics (NASDAQ: BBLG ) stock is rocketing higher despite a lack of news from the medical device company on Thursday. There are no new press releases or filings with the Securities and Exchange Commission that explain why BBLG stock is up today.
Most traders dream of hitting it big, and penny stocks are some of the most attractive for day traders. It can be any given session where we see at least a handful of cheap stocks under $5 explode.
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Shares of Bone Biologics Corp. BBLG plummeted 51.9% toward a record low in premarket trading Thursday, after the developer of regenerative medicine for bones announced the pricing of its relatively large stock offering at a deep discount. The company raised $5 million, as it said overnight that it sold 2.54 million shares, which represented 15.2% of the shares outstanding, at price of $1.97 per share.
Bone Biologics (NASDAQ: BBLG ) stock is breaking down on Thursday after the company announced the details of a public share offering. Bone Biologics has revealed its public offering prices shares of BBLG stock at $1.97 each.
What type of business is Bone Biologics?
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.
What sector is Bone Biologics in?
Bone Biologics is in the Healthcare sector
What industry is Bone Biologics in?
Bone Biologics is in the Medical Devices industry
What country is Bone Biologics from?
Bone Biologics is headquartered in United States
When did Bone Biologics go public?
Bone Biologics initial public offering (IPO) was on 13 October 2021
What is Bone Biologics website?
https://www.bonebiologics.com
Is Bone Biologics in the S&P 500?
No, Bone Biologics is not included in the S&P 500 index
Is Bone Biologics in the NASDAQ 100?
No, Bone Biologics is not included in the NASDAQ 100 index
Is Bone Biologics in the Dow Jones?
No, Bone Biologics is not included in the Dow Jones index
When does Bone Biologics report earnings?
The next expected earnings date for Bone Biologics is 14 August 2024